New study reveals gut microbiome’s critical role in aging and heart disease

FHS
June 10, 2024
3:55 am

Researchers in China discovered that gut microbiome diversity, influenced by metabolic health and age, significantly impacts cardiovascular disease risk.

Lyra pauses work on sinusitis drug; Pathos AI licenses a new asset

Plus, news about Convergent Therapeutics, Turnstone Biologics and Sonnet BioTherapeutics: Lyra Therapeutics pauses development of chronic rhinosinusitis drug: The company Sign up to read this

August 16, 2024

FDA Expands Approval of Ribociclib to Early Breast Cancer

The FDA on Tuesday approved ribociclib (Kisqali) in combination with endocrine therapy as adjuvant treatment for early high-risk breast cancer. Already approved in the metastatic

September 18, 2024

Sweet news: Dark chocolate reduces type 2 diabetes risk

Findings show dark chocolate may lower type 2 diabetes risk, while milk chocolate contributes to weight gain. Implications for dietary choices discussed.

December 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.